[{"Assets_0_Q2_USD":256589000.0,"CommonStockSharesOutstanding_0_Q2_shares":60501260.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-72280000.0,"NetIncomeLoss_2_Q2_USD":-72114000.0,"NetIncomeLoss_1_Q2_USD":-33655000.0,"StockholdersEquity_0_Q2_USD":213472000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":29891000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":19891000.0,"Ticker":"KPTI","CIK":"1503802","name":"KARYOPHARM THERAPEUTICS INC.","OfficialName":"Karyopharm Therapeutics Inc. Common Stock","form":"10-Q","period":"20180630","fy":"2018.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"566245834.0","Country":"United States","Sector":"Miscellaneous","Industry":"Diversified Commercial Services","Market":"NASDAQ","SP500":"nan","filed":"20180807"}]